further & higher education
health & social care
2

Effectively Tackling and Controlling Antimicrobial Resistance (AMR)

further & higher education

health & social care

08:45 - 16:20

Wednesday 2 October 2019

Central London

Early Bird Discount Offer

10% off all advertised rates for a limited time only. Discount available to public / voluntary organisations only

 

This Forum will provide participants with the opportunity to explore the latest strategies and policy updates designed to tackle the growing crisis of antimicrobial resistance (AMR) in the UK. Attendees will discuss with NHS England, Public Health England, The Health and Social Care Committee and other leading policy figures the implementation of the government’s Contained and Controlled: The UK’s 20-year Vision for Antimicrobial Resistance, 2019 and the next steps for reducing antibiotic usage. Additionally, best practice case studies will share innovative methods of effectively preventing AMR, reducing the number of drug-resistant infections and ensuring cost-effective and responsible prescribing.

Audience

This Forum is specifically designed for the Health Sector, Higher Education Sector and Local Government.

Job titles will include:

  • Chief Pharmacists
  • AMR Pharmacists
  • Microbiologists
  • Antimicrobial Resistance Officers
  • Infection and Prevent Control Leads
  • Lead Nurses
  • Nursing Directors
  • Clinical Service Directors
  • Quality Directors
  • Public Health Directors
  • Chief Nurses
  • Antimicrobial Technicians
  • Senior Professors
  • Medical Directors
  • Medical Researchers
  • Senior Health Researchers
Key Speakers Confirmed:
  • Karen Turner, Director, AMR Programme, NHS England
  • Susie Singleton, National Lead for Healthcare Associated Infections & Infection Prevention, Public Health England
  • Professor Chris Dowson, Chair, Science Committee, Antibiotic Research UK
  • Dr Tessa Lewis, Chair of Managing Common Infections Committee, NICE
View the agenda and additional speakers

Antibiotic resistance is predicted to kill 10 million people every year by 2050 if immediate action is not taken, according to the Independent Review on Antimicrobial Resistance. More than three million operations and cancer treatments could become life threatening per year without working antibiotics. Since 2013, the number of drug-resistant bloodstream infections increased in the UK by 35%. Furthermore, at least 20% of antibiotic prescriptions in primary care are inappropriate (according to Public Health England research, 2018). With 1 in 3 people in the UK taking antibiotics each year, the scale of this problem, therefore, cannot be underestimated. 

In January 2019, the Department of Health and Social Care released its 20-year vision and 5-year action plan for tackling antimicrobial resistance (AMR). These strategies outline how the UK will contain AMR by reducing drug-resistant infections by 10% by 2025 and decreasing antibiotic usage by 15% through direct, co-ordinated NHS and university action. It will also look to prevent over 15,000 NHS patients from contracting infections due to their healthcare in the next 5 years. This will be done by supporting clinicians to prescribe appropriately and by utilising the latest technology to collate patient data to drive a better understanding of when to use antibiotics. 

These plans have been backed up by significant funding and the delivery of targeted programmes. More than £360 million of government funding has been directed towards research and development on AMR across the NHS and Higher Education institutions. The AMR and Infections programme, developed by NHS England, Public Health England and Health Education England, has also been designed to support both NHS and social care staff in clinical and non-clinical roles to better recognise the signs of AMR and the routes by which to tackle this issue. 

The need to tackle AMR is paramount and, if strategic action is not taken now, this will become an ever increasing threat to human lives. Health practitioners working to tackle AMR now have access to a range of funding mechanisms and favourable policy changes, however if not effectively understood and implemented the impact of both funding and policy will be limited. This forum will provide the opportunity for the health and research professionals to strategise the best steps forward by understanding what is working and what is not with regards to tackling AMR, providing valuable takeaways which can drive forward the implementation of effective controls on AMR. 

08:45

Registration, Refreshments and Networking


09:30

Chair's Welcome Address

Professor Peter Wilson, Consultant Microbiologist, University College Hospital NHS Foundation Trust (CONFIRMED)


09:40

Morning Keynote: The NHS Vision – The Next Steps for Tackling Antimicrobial Resistance

  • Discussing the key indicators, strategies and objectives of the NHS 20 Year Vision and 5 Year Action Plan, which will drive action across the healthcare sector to reverse worsening AMR trends
  • Increasing clinician and non-clinician understanding of when and when not to prescribe antibiotics in order to reduce antibiotic usage by 15% by 2024
  • Looking at new technology and how it will be used to gather real-time patient data, helping clinicians understand when to use and preserve antibiotics in their treatment
  • Evaluating the importance of leadership in AMR, ensuring that appropriate prescribing behaviours are implemented, supporting the reduction of resistant infections

Elizabeth Beech, National Lead – Antimicrobial Resistance, NHS England (CONFIRMED)

Karen Turner, Director – AMR Programme, NHS England (CONFIRMED)

 


10:10

Keynote: Leading the National Campaign to Keep Antibiotics Working and Raise Public Awareness of AMR

  • Providing guidance to healthcare professionals through the All Our Health guidance, with a dedicated chapter towards best promoting antimicrobial stewardship
  • Launching, for the second year, the national campaign to Keep Antibiotics Working by highlighting to risk to lives across the UK if antibiotics are not prescribed and taken according to guidelines
  • Running the Become an Antibiotic Guardian programme to recognise good practice across the NHS, Social Care and Voluntary Sector with regards to exemplary and response antimicrobial prescribing practice
  • Evaluating the usage of the TARGET Toolkit (Treat Antibiotics Responsibly Guidance Education Tools) produced by PHE to help influence both prescribers and patients personal attitudes, social norms and perceived barriers to responsible AMR practice
  • Identifying the need to approach prescribing behaviours differently depending on the setting, such as through splitting these behaviours into three separate areas: primary care, patient behaviour and hospital care

Susie Singleton, National Lead for Healthcare Associated Infections & Infection Prevention, Public Health England (CONFIRMED)


10:40

Questions and Answers Session


11:00

Refreshments and Networking Session


11:20

Case Study: Implementing Innovations in Technology, Behaviour Change and Patient Safety To Improve Antimicrobial Use

  • Making sure that all antimicrobial stewardship interventions include behavioural components, including effectively targeting behavioural changes
  • Developing and implementing digital innovations such as apps, serious games, virtual reality, and decision support systems as stewardship interventions and to support optimal prescribing behaviours
  • Showcasing digital tools developed at Imperial College London, with an overview of available data and discussion of implementation and evaluation challenges
  • Leading the way in promoting competency based education to tackle the evident gaps that exist in AMR knowledge levels

Dr Enrique Castro-Sanchez, Lead Academic Research Nurse – Health Protection Research Unit in AMR, Imperial College London and Consultant Nurse in Communication & Patient Engagement, Imperial College Healthcare NHS Trust (CONFIRMED)


11:40

Case Study: Building a World-Leading University Research Programme to Fight Against AMR

  • Receiving £1 million of central government funding to speed up the generation of bacterial vaccines as part of the fight against AMR
  • Delivering a very extensive portfolio of projects by bringing together academic and healthcare industry workers to target bacterial diseases that can lead to AMR spreading and posing risks to human life
  • Creating one of the largest teams of microbiologists, across the European Union, devoted to controlling AMR through leading research by improving an understanding of the causes of AMR, how antibiotics function and precisely how bacteria cause infections
  • Targeting a multi-pronged approach which brings together antimicrobial stewardship, public education and education prevention under under one project
  • Growing this bacterial vaccinology network to a global level, with over 760 members across 67 countries now part of this project

Professor Calman A MacLennan, Director of BactiVac, University of Birmingham (CONFIRMED)

Professor Adam Cunningham, Co-Director of BactiVac, University of Birmingham (CONFIRMED)


12:00

Case Study: Drastically Reducing AMR Through Effective, Engaging Local Campaigning

  • Increasing AMR awareness across local communities through effective, engaging campaigning about good practice with regards to the intake of antibiotics
  • Working across the CCG, NHS Foundation Trust, Aston University and Birmingham City Council to organise awareness campaigns involving local schoolchildren, local adults and students across the university
  • Running a groundbreaking schools ‘AMR awareness poster competition’ for over 30 schools in Birmingham, with the winning schools having their posters on display in local GP surgeries
  • Organising targeted activities, such as the SuperBugs awareness game, across Aston university campus, the local hospital trust and GP practices which directly target patients and citizens to engage them in coversation about the risks and dangers of AMR

Awarded ‘highly-commended’ in the Public Engagement Category at the 2018 Antibiotic Guardian Awards

Rakhi Aggarwal, Senior Prescribing Adviser, NHS Birmingham and Solihull Clinical Commissioning Group (CONFIRMED)


12:20

Questions and Answers Session


12:40

Lunch and Networking


13:40

Afternoon Keynote: Funding Cross-Sector Research Collaborations to Tackle AMR and Support Preventative Strategies

  • Tackling AMR through extensive funding opportunities and collaborative research opportunities across the UK
  • Becoming a central means, through the AMR Funders’ Forum, for coordinating unilaterial, bilateral and multilateral funding programmes by identifying the key areas for future investment
  • Fostering cross-sector collaboration across the NHS, universities and the private sector to enable access for all to the appropriate data, tools and insights to stop the emergence of antibiotic resistant bacteria and support the discovery of new preventative strategies
  • Working with seven UK research councils to develop collaborative approaches which stretch between different research disciplines in order to cover all bases
  • Providing an overview of the impact of the UK AMR research output, including how it has helped to tackle AMR

Dr Jessica Boname, Head of Antimicrobial Resistance, Medical Research Council (UK Research and Innovation) (CONFIRMED)


14:00

Special Keynote: Funding High Quality, Effective Research Across Universities and the Healthcare Sector to Control AMR

  • Raising £5 million by 2021 to fund extensive research insight for universities and the healthcare sector to carry out in order to effectively tackle AMR in an evidence-based manner
  • Supporting education and awareness programmes to inform NHS staff and patients of the key causes of AMR and how people can be affected by AMR
  • Providing a step change in the development of new antibiotics, including faster and safer methods for the development of these antibiotics
  • Driving forward unique approaches to controlling AMR, such as combination usage of antibiotics, a project completed alongside the University of Cambridge which utlises artificial intelligence to predict the best combinations to over resistance

Professor Chris Dowson, Chair – Science Committee, Antibiotic Research UK (CONFIRMED)


14:20

Special Keynote: Ensuring Cost-Effective and Appropriate Antimicrobial Prescribing to Reduce AMR

  • Releasing NICE’s Antimicrobial Prescribing Guidelines to drive evidence-based clinical-based guidance to slow the pace of antimicrobial resistance and manage common infections
  • Understanding the cost-effective and evidence-based recommendations that NICE have developed on how to approach the challenge of AMR, in the face of research showing that as much as 23% of antibiotics are prescribed inappropriately
  • Discussing the overwhelming use of antibiotics in primary care and suggestions on how this can be reduced
  • Highlighting infections that have previously been prescribed antibiotics but, in recent times, have been shown to not need them, such as sinusitis, upper respiratory tract infections and urinary tract infections
  • Considering how secondary care has increased its prescription of antibiotics (7.7% from 2014-2017), believed to be due to the shortage of broad spectrum antibiotics, and innovative ways to lower this use

Dr Tessa Lewis, Chair of Managing Common Infections Committee, NICE (CONFIRMED)


14:40

Questions and Answers Session


15:00

Refreshments and Networking


15:20

Case Study: Building an Effective NHS-University Partnership to Drive Down AMR Through Innovation and Technology

  • Gaining £1.25 million of NHS funding for Newcastle’s NIHR MIC to invest in new technologies targeting innovative solutions to AMR
  • Bringing together researchers, clinicians, commissioners and patients to drive forward effective innovations, such as through Efficacy and Mechanism Evaluations, Health Technology Assessments, Inventions for Innovations and research for Patient Benefit
  • Utilising new technologies and treatments to reduce AMR by 50% as the key goal across the NHS Trust

Shortlisted for the Innovation and Technology Category at the upcoming 2019 Antibiotic Guardian Awards

Dr Joy Allen, Senior Clinical Test Evaluation Methodologist – NIHR Newcastle MIC, Newcastle University (CONFIRMED)

Dr Andrew Sims, Head of the Northern Medical Physics and Clinical Engineering Department (NMPCE) and Deputy Director – NIHR Newcastle MIC, Newcastle upon Tyne Hospitals NHS Foundation Trust (CONFIRMED)


15:40

Case Study: Strengthening Research, Education, Resources and Public Information on Antimicrobial Resistance

  • Sharing the latest cutting-edge and leading research findings from the Antimicrobial Resistance Centre, including how they can be applied to improve AMR prevention practices across the UK
  • Looking at the priorities and organisation of the AMR Centre and how they promote and facilitate high quality research into AMR that builds on and exploits disciplinary strengths across London School of Hygiene and Tropical Medicine
  • Prioritising education and cooperative practices in order to facilitate AMR related funding responses and collaboration opportunities
  • Learning from the centre’s strategy and organisational behaviour towards creating an interface for LSHTM’s AMR research for staff, public, press and wider research communities

Clare Chandler, Co-Director, Antimicrobial Resistance Centre, London School of Hygiene and Tropical Medicine (CONFIRMED)


16:00

Questions and Answers Session


16:20

Chair's Summary and Close

*Programme Subject to Change


You May Also Like

  • Working in Partnership to Tackle Health Inequalities

    10 October 201908:45 - 16:20

    Central London

    VIEW AGENDA